1 Intensive Care Unit, A.C. Camargo Cancer Center, São Paulo, Brazil.
2 Intensive Care Unit, Discipline of Medical Emergencies, Hospital das Clínicas, University of São Paulo, São Paulo, Brazil.
J Intensive Care Med. 2019 Oct;34(10):811-817. doi: 10.1177/0885066617716105. Epub 2017 Jul 5.
Patients with cancer represent an important proportion of intensive care unit (ICU) admissions. Oncologists and intensivists have distinct knowledge backgrounds, and conflicts about the appropriate management of these patients may emerge.
We surveyed oncologists and intensivists at 2 academic cancer centers regarding their management of 2 hypothetical patients with different cancer types (metastatic pancreatic cancer and metastatic breast cancer with positive receptors for estrogen, progesterone, and HER-2) who develop septic shock and multiple organ failure.
Sixty intensivists and 46 oncologists responded to the survey. Oncologists and intensivists similarly favored withdrawal of life support measures for the patient with pancreatic cancer (33/46 [72%] vs 48/60 [80%], = .45). On the other hand, intensivists favored more withdrawal of life support measures for the patient with breast cancer compared to oncologists (32/59 [54%] vs 9/44 [21%], < .001). In the multinomial logistic regression, the oncology specialists were more likely to advocate for a full-code status for the patient with breast cancer (OR = 5.931; CI 95%, 1.762-19.956; = .004).
Oncologists and intensivists share different views regarding life support measures in critically ill patients with cancer. Oncologists tend to focus on the cancer characteristics, whereas intensivists focus on multiple organ failure when weighing in on the same decisions. Regular meetings between oncologists and intensivists may reduce possible conflicts regarding the critical care of patients with cancer.
癌症患者在重症监护病房(ICU)入院患者中占很大比例。肿瘤学家和重症医学专家具有不同的知识背景,因此在这些患者的治疗管理方面可能存在分歧。
我们调查了 2 家学术癌症中心的肿瘤学家和重症医学专家,了解他们对 2 名不同癌症类型(转移性胰腺癌和转移性乳腺癌,雌激素、孕激素和 HER-2 受体阳性)患者的处理方法,这 2 名患者均发生感染性休克和多器官衰竭。
共有 60 名重症医学专家和 46 名肿瘤学家对调查做出了回应。肿瘤学家和重症医学专家对胰腺癌患者的支持治疗撤去措施的看法相似(33/46 [72%] vs 48/60 [80%], =.45)。另一方面,与肿瘤学家相比,重症医学专家更倾向于对患有乳腺癌的患者撤去更多的支持治疗措施(32/59 [54%] vs 9/44 [21%], <.001)。在多项逻辑回归中,肿瘤学专家更倾向于主张对患有乳腺癌的患者采取全面治疗方案(OR = 5.931;CI 95%,1.762-19.956; =.004)。
肿瘤学家和重症医学专家在癌症危重症患者的支持治疗措施方面存在不同意见。肿瘤学家倾向于关注癌症特征,而重症医学专家在权衡相同决策时则更关注多器官衰竭。肿瘤学家和重症医学专家之间定期开会可能会减少在癌症患者的重症治疗方面可能存在的冲突。